BZPEERPapers, people, evidence and research paths
Menu

Discover

SearchFind papers, people, topics, institutions and opportunities from one place.GraphSee how papers, authors, topics and evidence connect.

Research tools

HomeContinue from the papers, people and topics that matter now.CollectionsTurn saved papers into reading lists, evidence maps and shareable context.ResearchReconstruct the path that led you from search to paper to question.CollaborationMove from a paper, topic or expert request into a focused thread.PublishCreate full-text research articles with metadata, formulas and versions.

Network

ExpertsFind specialists whose work and reviews explain why they can help.CommunitiesJoin research groups organized around papers, topics and shared evidence.

Opportunities

ListingsBrowse roles, calls and collaborations connected to real research context.

Account

Log inReturn to your saved papers, graph views and active threads.Create accountStart saving papers, building a research trail and joining teams.
Log inCreate account

Source author record

Hamidreza Badri

Hamidreza Badri appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record
Tissues and Organsphysics.med-phmath.OCPopulations and Evolution

Catalog footprint

What is connected

3works
4topics
4close collaborators

Actions

Connect this record

Log in to claim
Open graphBrowse works

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

3 published item(s)

preprint2016arXiv

Optimizing chemoradiotherapy to target multi-site metastatic disease and tumor growth

The majority of cancer-related fatalities are due to metastatic disease. In chemoradiotherapy, chemotherapeutic agents are administered along with radiation to increase damage to the primary tumor and control systemic disease such as metastasis. This work introduces a mathematical model to obtain optimal drug and radiation protocols in a chemoradiotherapy scheduling problem with the objective of minimizing metastatic cancer cell populations at multiple potential sites while maintaining a minimum level of damage to the primary tumor site. We derive closed-form expressions for an optimal chemotherapy fractionation regimen. A dynamic programming framework is used to determine the optimal radiotherapy fractionation regimen. Results show that chemotherapeutic agents do not change the optimal radiation fractionation regimens, and vice-versa. Interestingly, we observe that regardless of radio-sensitivity parameters, hypo-fractionated schedules are optimal solutions for the radiotherapy fractionation problem. Furthermore, it is optimal to immediately start radiotherapy. However, for chemotherapy, we find that the structure of the optimal schedule depends on model parameters such as chemotherapy-induced cell-kill at primary and metastatic sites, as well as the ability of primary tumor cells to initiate successful metastasis at different body sites. We quantify the trade-off between the new and traditional objectives of minimizing the metastatic population size and maximizing the tumor control probability, respectively, for a cervical cancer case. The trade-off information indicates the potential for significant reduction in the metastatic population with minimal loss in primary tumor control.

0 citations0 reviewsNo code linkedOpen access
preprint2015arXiv

Minimizing Metastatic Risk in Radiotherapy Fractionation Schedules

Metastasis is the process by which cells from a primary tumor disperse and form new tumors at distant anatomical locations. The treatment and prevention of metastatic cancer remains an extremely challenging problem. This work introduces a novel biologically motivated objective function to the radiation optimization community that takes into account metastatic risk instead of the status of the primary tumor. In this work, we consider the problem of developing fractionated irradiation schedules that minimize production of metastatic cancer cells while keeping normal tissue damage below an acceptable level. A dynamic programming framework is utilized to determine the optimal fractionation scheme. We evaluated our approach on a breast cancer case using the heart and the lung as organs-at-risk (OAR). For small tumor $α/β$ values, hypo-fractionated schedules were optimal, which is consistent with standard models. However, for relatively larger $α/β$ values, we found the type of schedule depended on various parameters such as the time when metastatic risk was evaluated, the $α/β$ values of the OARs, and the normal tissue sparing factors. Interestingly, in contrast to standard models, hypo-fractionated and semi-hypo-fractionated schedules (large initial doses with doses tapering off with time) were suggested even with large tumor $α$/$β$ values. Numerical results indicate potential for significant reduction in metastatic risk.

0 citations0 reviewsNo code linkedOpen access
preprint2015arXiv

Robust and probabilistic optimization of dose schedules in radiotherapy

We consider the effects of parameter uncertainty on the optimal radiation schedule in the context of the linear-quadratic model. Our interest arises from the observation that if inter-patient variations in OAR and tumor sensitivities to radiation or sparing factor of the OAR are not accounted for during radiation scheduling, the performance of the therapy may be strongly degraded or the OAR may receive a substantially larger dose than the maximum threshold. This paper proposes two radiation scheduling concepts to incorporate inter-patient variability into the scheduling optimization problem. The first approach is a robust formulation that formulates the problem as a conservative model that optimizes the worst case dose scheduling that may occur. The second method is a probabilistic approach, where the model parameters are given by a set of random variables. This formulation insures that our constraints are satisfied with a given probability, and that our objective function achieves a desired level with a stated probability. We used a transformation to reduce the resulting optimization problem to two dimensions. We showed that the optimal solution lies on the boundary of the feasible region and we used a branch and bound algorithm to find the global optimal solution. We observed that if the number of fractions in the optimal conventional schedule is the same as the robust and stochastic solutions, it is preferable to administer equal or smaller total dose. In addition if there exist more (fewer) treatment sessions in the probabilistic or robust solution compared to the conventional schedule, a reduction in total dose squared (total dose) will be expected. Finally, we performed numerical experiments in the setting of head-and-neck tumors to reveal the effect of parameter uncertainty on optimal schedules and to evaluate the sensitivity of the model to the choice of key model parameters.

0 citations0 reviewsNo code linkedOpen access